retatrutide triple agonist obesity trial VisualAbstract: reduces body weight by 17.5% in patients with Experimental drug retatrutide cut weight

Chief Medical Officer at Noom, Dr

Triglyceride reduction of 28% addresses a major cardiovascular risk factor

Dosing patterns for hormonal phases While the standard prescribing information for GLP-1 medications like semaglutide or tirzepatide does not include official information for customized dosing based on a patients hormonal phases, there is emerging clinical practice and research focusing on personalized dosing strategies, particularly for women experiencing hormonal shifts

Reaching my breaking point During the pandemic my life took a turn for the worse

In my opinion, then, GLP-1 adoption could serve as a demand-side sustainability tool that reduces total beef production while addressing obesity

Severe constipation, painful bloating, vomiting, inability to pass stool or gas, or constipation that does not improve should be discussed with a doctor promptly